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IT was soon realised, following the original description by Kinosita (1940)
of the development of hepatic tumours in rats treated with p-dimethylamino-
azobenzene (DMAB), that the composition of the basal diet was of considerable
importance in influencing the rate of development and yield of tumours. As
a result of numerous investigations, factors in the diet which either retard or
hasten tumour development have been described; these have been reviewed
by Orr (1947). It must be stressed, however, that no agent has thus far been
described which will completely inhibit hepatic tumour development provided
the carcinogen is administered long enough.
In previous experiments (Wyatt and Howell, 1953) an unsuccessful attempt
was made to produce pigmentary cirrhosis in rats maintained on a corn-grit
diet supplemented with copper acetate and ferric citrate. As DMAB is an
agent known to be capable of inducing cirrhosis it was decided to repeat these
experiments including DMAB in the diet. The results of this experiment are
nowreported since it became apparent that copper acetate had a markedinhibitory
effect on hepatic tumour development and cirrhosis.
MATERIALS AND METHODS
General
The experiments were carried out in two series. In Experiment A the rats
were derived from entirely out-bred laboratory stock, in Experiment B, rats
from aheterozygous strain were employed (Laboratory Animals Bureau Catalogue
of Uniform Strains, No. 626, 1953; the Birmingham strain).
In both experiments the animals, whose age varied between 2 and 6 months
at the start oftheexperiment, werekept ingalvanisedwire mesh cages, never more
than 5 rats to a cage. The various diets were moistened with water to prevent
the scattering of feed, and placed in galvanised troughs in the cage every
morning. The amount of food given was calculated on the basis of 10 g. per
rat per day. Water was available ad lib. In Experiment B, to check the
quantity of food consumed by the rats in each cage, at certain times the residue
was dried and weighed.
After the third month oftreatment all the animals were examined at approxi-
mately 14 day intervals to determine the presence of palpable liver tumours.
In Experiment A, animals with tumours were allowed to live their full term, or
until the tumour became so large as to be incapacitating. In Experiment B
the animals were usually killed as soon as, or shortly after, a tumour had become
palpable.COPPER ACETATE AND DMAB CARCINOGENESIS
Composition andpreparation ofdiets
Two basic forms of diet were used: finely ground maize (obtained from a
local dealer) was substituted for corn-grits, since these were unobtainable locally
and rat cube powder. The latter was derived from rat cubes (Heygate and Sons,
known as the Thompson diet). The Thompson diet is well balanced and has
been found to maintain normal growth and nutrition. The biochemical compo-
sition of maize varies from season to season. It is very rich in nitrogen-free
extract, mainly starch, and has a relatively high fat content. It never contains
more than 10 per cent protein, principally zein, which is of poor biological value,
and is deficient in two essential amino acids: lysine and tryptophane. Attention
has been drawn to the badly balanced character of the amino acids present in
zein (Gillman and Gilbert, 1954). The ergosterol, niacin, choline, riboflavin,
calcium and phosphorus content is low.
Maize is of poor nutritional value for rats and when it is used as the sole
source of food growth is retarded. Even when it is supplemented with lysine
and tryptophane growth is still retarded and its protein value is not equivalent
to that of casein (Hogan et al., 1955).
The maize and cube powder were weighed and dry crystalline DMAB was
added to a concentration of 0 09 per cent. Powdered copper acetate and/or
ferric citrate were added in concentrations of 0 5 per cent and 2-0 per cent respec-
tively. The diets were shaken until an intimate admixture was obtained and
were stored in enamel bins. They were freshly prepared at approximately 10
day intervals.
Dietary groups
Experiment A.-Forty rats were divided into 4 groups, with equal numbers
ofmales and females in each group. The appropriate diet for each group (Table I)
was given continuously throughout the life of the animals. When the results
of this experiment were analysed and it had become apparent that some factor,
presumably copper acetate, was affecting the carcinogenic process it became
necessary to determine whether or not in fact the copper salt was the inhibiting
agent and that the inhibition was not due to the combined effect of the copper
and iron salts. Furthermore, the possibility that copper interfered with the
intestinal absorption of DMAB, or even combined with it in the intestinal tract,
had to be considered. Accordingly, a second experiment was arranged.
TABLE I.-Experiment A (Groups 1, 2, 3 and 4). Diets
Number of rats
Group Male Female Diet
1 5 5 CP + Fe cit + DMAB.
2 5 5 M + Fe cit + DMAB.
3 5 5 . CP + Fe cit + Cu ac + DMAB.
4 . 5 5 M + Fe cit + Cu ac + DMAB.
CP = Cube powder, M = Maize, Fe cit = 2-0 per cent Ferric citrate, Cu ac = 0 5 per cent
Copper acetate, DMAB = 0 09 per cent p-Dimethylaminoazobenzene.
Experiment B.-Seventy rats were divided into 7 dietary groups with equal
numbers of males and females in each group. To confirm that copper acetate
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was the inhibiting agent 3 dietary groups were arranged (Table II). The other
dietary groups in this experiment were designed to reduce the likelihood of copper
acetate interfering with DMAB absorption or of combining chemically with it
in the gut. For this purpose a system of alternating feeding was devised in
which the copper acetate and DMAB components of the diet were given on
different days (Tables III and IV). An additional group was included to compare
the protective effect of copper acetate with the protection afforded by a normal
diet given on alternate days.
TABLE II.-Experiment B (GroUps 5, 6 and 7). Diets
Number of rats
A
Group Male Female Diet
5 . 5 5 . M + DMAB.
6 . 5 5 . M + DMAB + Cu ac.
7 . 5 5 . M + DMAB + Fe cit.
M = Maize, DMAB = 0 09 per cent p-Dimethylaminoazobenzene, Cu ac = 0 5 per cent Copper
acetate, Fe cit = 2- 0 per cent Ferric citrate.
TABLE III.-Experiment B (GroUps 8, 9, 10 and 11). Diets: DMAB
and Copper Acetate Components Given Separately
Number of rats
__________A _______ Number ofdays
Group Male Female Diet per week
8 . 5 5 . M + DMAB + Fe cit . 4
M + Cuac . 3
9 . 5 5 . M + DMAB + Fe cit . 5
M + Cuac . 2
10 . 5 5 . M + DMAB + Fe cit . 6
M + Cu ac . 1
11 . 5 5 . M + DMAB + Fe cit 4
CP . 3
M = Maize, CP = Cube powder, Fe cit = Ferric citrate, Cu ac = Copper acetate, DMAB = 0-09
per cent p-Dimnethylaminoazobenzene.
TABLE IV.-Experiment B (Groups 8, 9, 10 and 11).
To Show Days of Week on Which DMAB or Copper Acetate Was Given
Group Monday Tuesday Wednesday Thursday Friday Saturday Sunday
8 . Cu ac . DMAB . Cu ac . DMAB . Cuac . DMAB . DMAB
9 . ,, . ,, DMAB ... ...
10 .DMAB oi . . .. ...
11 . CP . ,, . CP . ,, . CP . ..
Basal diet maize, except where CP is indicated.
Specialprocedures
In Experiment A rats were subjected to liver biopsy under anaesthesia. They
were biopsied in rotation at monthly intervals, from the second to the tenth
months of the experiment. During Experiment B, liver function was assessed
by means of the bromsulphalein excretion test.COPPER ACETATE AND DMAB CARCINOGENESIS
In Experiment B the animals were weighed regularly, and it was found that
all animals gained weight, although at a slower rate than normal. Duriilg
the first month of the experiment animals in Group 6 showed a loss of weight
which was later slowly regained. This initial loss was thought to be due to
abstention from food. Animals of this group were all heavier than animals of
other groups and hence were better able to undergo voluntary starvation rather
than consume an unpalatable diet.
At intervals, over periods of one month the quantity of food consumed by
the animals was estimated by weighing the residues daily. The results obtained
are only a rough guide to the quantity of food consumed since no allowance
was made for spillage or for individual variations in consumption, but it was
found that the animals in the various dietary groups consumed roughly the
same amounts offood.
It was essential to determine whether or not DMAB underwent any chemical
alteration when it was mixed and stored with maize and copper acetate. For
this purpose column chromatography was undertaken on diets which had been
prepared and stored for about 2 months prior to the test. Columns were prepared
from a slurry of alumina (B.D.H. activated), ligroin extracts of two diets, one
consisting of maize and 0 09 per cent DMAB, the other of maize, 0 09 per cent
DMAB and 0.5 per cent copper, were dropped on the columns and washed
through with suitable solvents. These two columns were compared with
similarly prepared columns of DMAB alone, and of a mixture of DMAB and
4-aminoazobenzene. A clear separation of the two components of the last
column was obtained, DMAB flowing faster than 4-aminoazobenzene. The
columns containing extracts of the diets gave only one component corresponding
to DMAB. Further experiments were undertaken to determine if there was any
reduction in the quantity of DMAB in the prepared stored diets. The dye
was extracted from the diet and estimated colorimetrically on the day the diet
was prepared and thereafter at weekly intervals for 6 weeks. No decrease in
the amount of dye was detected during this period.
Post-mortem examination and histological methods
Blocks of tissue from the liver and spleen were preserved for microscopic
study, together with any other tissue which showed pathological changes. At
least two blocks were taken from every liver; frequently, and especially when
more than one tumour was present, several blocks were taken, although no
attempt was made to section every tumour.
The tissue was fixed in 4 per cent formaldehyde-saline or occasionally in
Bouin's fluid. Sections were stained with Ehrlich's haematoxylin and eosin,
Weigert's haematoxylin and Van Gieson, and by the periodic-acid-Schiff method
using a diastase-treated control. Perls' reaction for ferric iron was carried
out on all sections. Other stains used, included Gomori's reticulin method and
Best's carmine stain for glycogen. Frozen sections were cut and stained for
fat. Special histochemical stains for copper were also employed.
RESUILTS
The first animal to develop tumours in both Experiment A and B died during
the sixth month. Hence this period has been taken as the minimum induction
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period and animals that died before this time have been excluded since they
were not " at risk ". The results in the two experiments are detailed in Tables V
and VI.
TABLE V.-.Experiment A. Details of Tumour Incidence
Group
Animals " at risk "
Months to first tumour
Other animals alive at time of first tumour
Number developing tumours
Average induction time and range
(months)
Average time to death and range .
(Months)
1 2
10 9
9 6
9 8
8 8
13.6 11-25
(9-16) (6-16)
13.0 11-0
(9-16) (6-16)
3
8
11
5
4
14*0
(11-16)
12-5
(8-16)
4
8
No tumour
0
13-5
(10-16)
Animal " at risk " = animals surviving more than 6 months.
TABLE VI.-Experiment B. Details of Tumour Incidence
Group
t
A
Animals " at risk "
Months to first tumour
Other animals alive at time offirst
tumour
Number developing tumours
Average induction time and range
(Months)
Average time to death and range
(Months) .
5 6 7 8 9
8 8 10 10 8
6 18 6 15 9
7 0 9 7 5
8
8-5
(6-10)
8*5
(6-10)
1
13*3
(10-18)
10
8*5
(6-12)
8*5
(6-12)
3
15
15*1
(8-19)
Animals " at risk " = animals surviving more than 6 months.
Experiment A (Table V)
Group 1.-Ten animals survived 6 months, of which 8 developed tumours.
The first tumour was found at 9 months, at which time 9 other animals were
alive. Other tumours appeared between 9 and 16 months (average 13*6 months).
The 2 rats without tumours died after 9 and 12 months' treatment.
Group 2.-Nine animals survived 6 months, of which 8 developed tumours.
The first tumour was found at 6 months, at which time 8 rats were alive. Other
tumours appeared between 6 and 16 months (average 11 25 months). The animal
without a tumour died at 9 months as a result of liver biopsy.
Group 3.-Eight animals survived 6 months, but only 4 developed tumours.
The first tumour was found at 11 months, at which time 5 rats were surviving.
Other tumours appeared between 11 and 16 months (average 14 months). The
2 animals without tumours died during the eleventh and fourteenth months of
treatment.
Group 4.-No animal developed a tumour in this group although 8 survived
treatment for 6 months. They died between 10 and 16 months (average 13-5
months).
CJomment.-In Groups 1 and 2 combined, only 3 animals died without tumours.
However, there was a difference between the two groups of 2-3 months in the
10
10
9
9
8
12
(9-15)
11*4
(9-15)
11
9
15
5
16-2
(15-18)
14*1
(9-18)
6
11*3
(9-15)
10.5
(8-15)
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average tumour induction time. This difference may indicate a protective
effect of rat cube due to its greater nutritional value as compared with maize.
When copper acetate was given with the carcinogen in a maize diet (Group 4)
no tumours were found despite the fact that the group survived for an average
period of 13-5 months, i.e. 2-25 months longer than the corresponding group
without copper (Group 2). With a cube and copper diet (Group 3), 4 ofa possible
8 animals developed tumours, the average time of tumour development being
14 months. Although this is only 0 4 months longer than in the corresponding
group without copper (Group 1), the first tumour in Group 3 did not appear
until the eleventh month, whereas the first tumour in Group 1 appeared during
the ninth month. In Group 1, furthermore, 8 animals out of a possible 10
developed tumours.
It is apparent from these results that diets containing ferric citrate and copper
acetate, especially when incorporated into a maize diet, afford a considerable
degree of protection against hepatic tumour development. When given in
conjunction with a rat cube diet the protection is not so marked. Chemical
analyses suggest that copper storage in the liver is greater in maize-fed animals
than in cube-fed animals. This might be an important factor in determining the
difference in tumour yield between the two basal diets.
Experiment B (Table VI)
Groups 5 and 7 may be considered together. In both groups the first tumours
developed during the sixth month, and all the animals " at risk " developed
tumours. The average time to death in both groups was 8-5 months.
Group 6.-Eight rats survived 6 months. One tumour was found during the
eighteenth month in the sole survivor of the group. The other 7 animals had
died in 10-S15 months (average 13*3 months).
Group 8.-All 10 rats survived treatment for 6 months. Three tumours
developed in the fifteenth month. The remaining 5 animals died between 16
and 19 months without tumours.
Group 9.-Eight animals survived 6 months' treatment, 6 of which subse-
quently developed tumours, the first being found after 9 months. The average
time to death in tumour bearing animals was 11-3 months. The 2 animals
without tumours died during the eighth month.
Group 10.-Ten animals survived 6 months' treatment, ofthese, 8 subsequently
developed tumours, the first being found during the ninth month. The other
tumours were found between 11 and 15 months, and the average time to death
due to tumour development was 12 months.
Group 11.-Nine animals survived 6 months' treatment, of which 5 developed
tumours. The first tumours, 3 in number, were found after 15 months. The
other 2 tumours appeared at 18 months. The average time to death due to
tumour development was 16-2 months. Animals died between the ninth and
sixteenth months, but none had tumours.
Comment.-There is a difference in the time of death due to tumour develop-
ment in Experiments A and B when groups comparable, except for the addition
of ferric citrate, are considered. This difference arises from differences in
experimental technique. In Experiment A the animals were allowed to live
until moribund or until they died as a result of tumour growth. Liver biopsies
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were done in strict rotation and no special effort was made to biopsy those
suspected of having tumours. During Experiment B, when the animals were
submitted to bromsulphalein excretion tests, careful abdominal palpation was
carried out under anaesthesia. An effort was made to test all the animals
suspected of having tumours as soon as they developed, and with certain excep-
tions they were then killed. In this way tumours were found at an earlier
stage of development than in Experiment A. In addition, since there is some
evidence that strains differ in their susceptibility to the carcinogen (Sugiura
and Rhoads, 1941), part of the difference in average induction times may be
due to the different strains of rat used in the two experiments.
In Experiment B it has been confirmed that copper acetate is a powerful
tumour inhibiting agent and that ferric citrate is without effect on the carcino-
genic process. In Group 6 receiving copper acetate, none ofthe 8 animals at risk
died before the tenth month, by which time all the animals of Group 5 had
developed and died with tumours. The solitary tumour in Group 6 did not
appear until the eighteenth month. The average time to death for this group,
excluding the animal with a tumour, was 12-7 months, i.e. 4-2 months longer
than in Group 5.
The results of the alternating feeding experiments are more difficult to
interpret since it is not certain how many of the effects observed were due to the
reduced DMAB consumption or to the supplementary copper. Groups 8 and 11
may be compared. In both, tumours developed in several animals during the
fifteenth month of treatment; excluding these animals there were 5 survivors
in Group 8 and 3 survivors in Group 11. None of the survivors in Group 8
developed tumours even though 3 of them lived to the nineteenth month of
treatment; but 2 of the 3 survivors in Group 11 developed tumours during
the eighteenth month. Considering the nature of the basal diet of these groups,
the expectation oftumour development is greaterin Group 8, which received maize
every day, than in Group 11, which received cube or maize on alternate days.
Despite this the tumour incidence was less in the copper-treated group. It
would thus appear that the inhibitory effect of copper feeding is just apparent
in Group 8.
When Group 8 is compared with Groups 9 and 10 it can be seen that tumour
inhibition is much less in the two latter groups. In Groups 9 and 10 the first
tumours appeared during the ninth month and all the animals dying subsequently
had tumours. The prolongation of the time to the first appearance of tumours
in these two groups, together with the prolongation of the average induction
times when compared with Group 7, appear greater than can be accounted for
by the omission of DMAB from the diet for one or two days of each week and
may be due in part to the addition of copper acetate to the diet.
PATHOLOGY
Biopsy material (Experiment A)
Histological assessment of the tissue obtained from 33 animals between the
second and tenth months of dietary treatment allows comparisons to be made
between animals of the 4 dietary groups. However, since only one specimen
of liver is available from each group per month, it cannot be assumed that the
changes in that one specimen are representative of the whole group at that
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particular time. Nevertheless, the material does reveal differences among
the dietary groups, both in severity and rate ofdevelopment oflesions.
The early microscopical changes which follow the administration of DMAB
have been described by Orr (1940), and Opie (1944) and a detailed description
is unnecessary. In general the effect of DMAB is to cause the gradual piecemeal
destruction of liver cells, at first in a zone adjacent to portal tracts and later
throughout the lobule. This is followed by regenerative hyperplasia without
normal lobular architecture. This may consist of intralobular disorganisation
in which foci of regenerative cells within a lobule show a derangement of the
normal radial pattern of liver cell cords, frequently with signs of pressure
distortion of surrounding liver cell cords and displacement of the central vein
of the lobule (Fig. 1). Regenerative hyperplasia may progress to nodular hyper-
plasia in which varying sized nodules ofregenerating liver cells are formed without
normal lobular architecture (Fig. 2). These nodules are often formed from
the remains of several liver lobules. Concurrently with these changes, portal
tracts show infiltration with chronic inflammatory cells and macrophages (Fig. 3)
At first confined to portal tracts, these cells extend into adjacent parts of the
liver lobule and towards other portal tracts. They are accompanied by reticulin
fibres (Fig. 4) which are gradually superimposed by collagen and eventually a
multilobular cirrhosis is produced (Fig. 2). Bile duct proliferation and dilatation
also occurs, proliferation is first seen in the form of double rows of fusiform cells
with poorly defined cell borders and large oval nuclei, poor in chromatin. These
cells accompany the chronic inflammatory cells as they extend from the portal
tracts (Fig. 5 and 6).
The development of cirrhosis and regenerative hyperplasia form a convenient
means of assessing the liver damage. The development of cirrhosis can be
arbitrarily divided into 3 grades: periportal fibrosis or incipient cirrhosis, and
early and advanced cirrhosis. Periportal fibrosis (incipient cirrhosis) is a very
early stage, in which the newly formed fibrous tissue is either confined to the
portal tracts or at the most, thin strands of fibrous tissue extend only a little
way into the adjacent parenchyma (Fig. 7). Macroscopically the liver is always
smooth.
Early cirrhosis is a later stage, in which thin strands of fibrous tissue extend
a considerable way around liver lobules and pseudo-lobules (Fig. 8). Slight
granularity may or may not be seen on macroscopic examination.
In advanced cirrhosis the fibrous tissue is denser and the strands thicker than
that described above. The strands frequently completely encircle the lobules
and regeneration nodules, and the appearances resemble human multilobular,
Laennec-type cirrhosis (Fig. 2). At this stage the liver is always macroscopically
granular.
In Table VII is given the detailed incidence of the various grades of cirrhosis
assessed on the maximum seen in any section, together with the presence or
absence of regenerative hyperplasia of liver tissue in the 4 dietary groups. In
the material from 8 rats of Group 4 no evidence of cirrhosis or of hyperplasia
was seen. Material from a similar number of rats is available from Group 1,
5 of which showed varying grades of cirrhosis; in 4 regenerative hyperplasia
was present. In only 3 animals was cirrhosis absent. In Group 3, material was
available from 9 rats; 3 showed regenerative hyperplasia and only one showed
evidence of cirrhosis. From Group 2, 8 rats were subjected to biopsy; 6 of
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them revealed regenerative hyperplasia, and 7 showed some degree of cirrhosis.
In only one animal was cirrhosis absent.
TABLE VII.-Experiment A. Number of Biopsies in Each Group Related to the
Number of Animals Showing Regenerative Hyperplasia and Cirrhosis of the
Liver
Degree of cirrhosis
Number of Regenerative
Group biopsies hyperplasia Absent Incipient Early Advanced
1 8 4 3 2 3
2 . 8 6 . 1 3 3 1
3 . 9 . 3 . 8 - 1 -
4 . 8 . . 8 -
It is apparent that liver damage was considerably less in Group 4 than in
the other 3 groups. In this group the histological changes appeared to be
arrested, at least during the period under study, following the development of
increased periportal cellularity associated with fusiform cell proliferation. Liver
cell damage was nearly always confined to cells adjacent to portal tracts.
Nevertheless, it must be stressed that the histological changes in this group
were all of the type which follow DMAB administration.
From the biopsy material an estimate can also be made of the rate of
development of hepatic damage. Thus, in Group 1 the specimen obtained at
3 months showed early cirrhosis. In the specimen at 4 months the liver showed
incipient cirrhosis with regeneration and a marked tendency for fusiform cells
to encircle hepatic lobules. Similar processes were observed in all the other
animals studied; a tumour was found during the ninth month.
In Group 2, at 2 months a very severe degree of liver damage was found with
early cirrhosis and nodular hyperplasia. It seems most likely that the severity
of the lesions was exceptional in the particular rat examined. In the following
months the specimens all showed some degree ofcirrhosis with regenerative hyper-
plasia. At 6 months a tumour was found.
It was not until the fourth month that pronounced changes were observed
in Group 3 rats, even then the animal appeared to be an exception in that the
liver showed early cirrhosis and nodular hyperplasia. No cirrhosis was found
in this group subsequently, and further, although at 6 and 7 months intralobular
disorganisation was present, specimens at 8 and 9 months showed only minimal
changes.
In Group 4 it was not until the eighth month that marked changes were seen,
consisting of fusiform cells and chronic inflammatory cells tending to encircle
lobules.
From these observations it is apparent that hepatic injury developed and
progressed rapidly in Group 2 rats, followed closely by rats from Group 1. Group 4
animals showed a very considerable retardation in the severity of the lesions
and a considerable prolongation in the time required to produce them.
Histological changes in animals dying without tumours
An assessment of the changes seen in these animals is included since they
supplement the observations made on the biopsy material and help to evaluate
still further the protective effect of copper acetate.
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In Experiments A and B combined 37 animals failed to develop tumours
after surviving a minimum of 6 months' treatment with DMAB. With the
exception of Groups 5 and 7, every group contained one or more animals without
tumours.
The tumourless animals can be divided into 3 groups: those that did not
receive copper acetate, those that received copper acetate continuously, and
those that received copper acetate on certain days of the week only. The assess-
ment of liver damage in these groups can be based on the criteria used for the
assessment ofthe biopsy material. The detailed results are set out in Table VIII.
TABLE VIII.-CirrhoSis in Animals Without Tumours in Experiments A and B
Animals Degree of cirrhosis
Animnals without Regenerative A
Group "at risk" tumours hyperplasia Absent Incipient Early Advanced
1 . 10 2 2 . 2 -
2 9 1 1 1 - -
3 8 . 4 . - 2 2 - -
4 8 8 4 . 3 4 1
6 8 . 7 . 5 2 3 1 1
8 10 . 7 . 5 2 2 3
9 . 8 . 2 . 2 . 2 -
10 10 . 2 . 2 . 1 1
11 9 . 4 1 4 -
Animals "at risk" = animals surviving more than 6 months.
Only 3 animals given DMAB without copper acetate (Groups 1 and 2) did not
develop tumours. Regenerative hyperplasia associated with incipient or early
cirrhosis was present in all 3.
Groups 3, 4 and 6 received DMAB and copper acetate continuously, and a
total of 19 animals did not develop tumours. Regenerative hyperplasia was
present in 9 ofthese animals ; incipient cirrhosis was observed in 9, early cirrhosis
in one, and advanced cirrhosis in 2. Cirrhosis was completely absent in 7. After
the thirteenth month all the animals dying in these groups had developed incipient
cirrhosis and intralobular disorganisation.
There were 15 animals without tumours in the remaining groups receiving
DMAB and copper acetate separately. In 10 of these, regenerative hyperplasia
was observed; incipient cirrhosis was present in 5 and early cirrhosis in 3. No
animal showed advanced cirrhosis, and in 7, cirrhosis was completely absent.
These observations show quite clearly that the microscopical changes in
the DMAB, copper-treated rats are of the same nature as those which result
from DMAB alone, but there is a delay in the rate ofdevelopment and progression
of the lesions especially marked during the first 12 months of treatment. Many
of the animals receiving DMAB and copper eventually developed varying grades
of cirrhosis, the incipient type predominating. In some animals this was accom-
panied by regenerative hyperplasia, frequently associated with bile duct pro-
liferation and dilatation; but by the time these changes had developed, all the
animals treated with DMAB alone had developed and died with tumours. Never-
theless, the impression is gained from the histological material that had the
copper-treated animals survived, and had treatment been continued long enough,
some tumours would eventually have been produced. In fact one tumour did
develop during the eighteenth month of treatment in a rat from Group 6.J. S. HOWELL
Tumours and cirrhosis
Two ofthe tumours produced by DMAB are derived from bile duct epithelium,
they are the bile duct cystadenoma and the cholangiocarcinoma; a third tumour
is derived from liver cells, the hepatoma. The gross and microscopic features
of these tumours have been described in detail by numerous workers and since
the tumours produced in the present experiments did not differ in any way
from those previously described a detailed account is unnecessary. The lesion
known as cholangiofibrosis also arises from bile duct epithelium and must be
considered a premalignant lesion because in common with Opie (1944) and Fir-
minger (1955) I have observed transitions between this lesion and cholangio
carcinoma.
In Experiments A and B combined, a total of 61 animals developed tumours.
In 41 of these animals the tumours were of 2 or more histological types, and
were frequently intimately admixed. In the remaining 20 only one tumour
was present in each liver, the tumour varying in histological type. This incidence
of multiple tumours in the liver has been noted previously by several workers.
The tumours which occurred in the animals receiving different amounts of copper
in the diet did not exhibit any unusual features.
Macroscopic cirrhosis usually accompanies the appearance of DMAB induced
hepatic tumours, but it is not an essential precursor (Miller et al., 1941; Opie,
1944; Hoch-Ligeti, 1946). However, in the presence of cirrhosis the tumour
yield is increased and the induction time decreased. In the present experiments
a portion of non-tumorous liver tissue was taken for histological examination
from all the animals with hepatic tumours. The degree of cirrhosis was assessed
in the same manner as in the biopsy material. In the 61 animals with tumours,
cirrhosis was absent in only 4 instances. Incipient cirrhosis was present in 12,
early cirrhosis in 22 and advanced cirrhosis in 23. These figures show the close
association between the development of hepatic tumours and the presence of
cirrhosis. They can be contrasted with the incidence and degree of cirrhosis in
the 37 non-tumour bearing animals in which cirrhosis was absent in 14, incipient
in 15, early in 6, and advanced in 2.
Splenic changes
Splenic enlargement, developing early in the course of DMAB carcinogenesis,
was described by Orr (1940). This enlargement was present before the liver had
developed microscopical changes and became maximal during the third and
fourth months of treatment, thereafter tending to shrink. Enlargement of the
spleen was also observed by Edwards and White (1941) and Hoch-Ligeti (1946).
During Experiment B all spleens were weighed at post-mortem examination.
In Groups 5 and 7 receiving DMAB with or without ferric citrate but no copper
acetate, the mean splenic weight in the 2 groups was approximately equal (2.3 g.
and 2-2 g. respectively), and approximately 1P0 g. heavier than the mean weight
of the spleen in Group 6 (1.1 g.), which received DMAB and copper acetate.
The difference in the splenic weights of the directly comparable groups, 5 and 6,
was significant (0.02 > P > 0-01).
In the other part of Experiment B where the diets were alternated, Groups 9
and 10 had the largest spleens; these groups received the smallest quantities
of copper and the largest quantity of DMAB. In Groups 8 and 11 the mean
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weights of the spleen were approximately equal, but the mean weight of both
was greater than in Group 6.
As the spleen enlarges during DMAB treatment its normally sharp edges
become rounded, the colour becomes darker; later the surface is dulled and shows
slight granularity with pitting. The consistency is much firmer than normal.
Microscopically, the spleen is congested at first, later varying degrees of
fibrosis develop. The fibrous trabeculae may become much more prominent and
thicker than normal (Fig. 9). In some spleens fibrous tissue is formed in the
Malpighian bodies which may become almost completely replaced by collagen
(Fig. 10). In this type of fibrosis many Malpighian bodies are usually involved.
Another variant is where fibrous tissue is present in rather localised areas in the
pulp thickening the walls of the sinusoids (Fig. 11).
These gross and microscopic changes, which are essentially the same as those
described by Orr (1940), are also observed in copper acetate treated rats, but the
changes in these animals were always much less advanced than in those animals
given DMAB without copper acetate.
No correlation was observed between the weight of the spleen and any of
the following changes in the liver: liver weight, tumour type, the presence or
absence of cirrhosis or regenerative hyperplasia. In certain animals splenic
enlargement and congestion were observed without marked pathological change
in the liver, and splenic fibrosis was observed without cirrhosis. These observa-
tions suggest that the splenic changes are not due to vascular obstruction in the
liver, with consequent portal hypertension.
DISCUSSION
There are other reports in the literature dealing with the effect of copper
on azo-dye carcinogenesis which show that the protection is probably inde-
pendent of the type of salt used, since both copper acetate and copper sulphate
have been found to be effective. Sharpless (1946) in a study of trace-elements
and azo-dye carcinogenesis used low-riboflavin diets containing DMAB supple-
mented by 0*15, 0-3 and 0.5 per cent copper sulphate. No effect was observed
on tumour incidence but the induction time was increased by 25-50 per cent
as compared to that observed with the control diets. No other details are given
in this short report, except that the non-malignant liver damage was always
less than in the controls.
During the early stages of the present experiments Pedrero and Kozelka
(1951) added copper (the salt used was not stated) to a diet containing the
carcinogen 3'-methyl-4-dimethylaminoazobenzene which is structurally related
to DMAB. The concentration of copper was either 0-25 or 0 5 per cent. The
experiments were terminated after treatment for 6 months. The control group
receiving the carcinogen without copper contained 30 animals of which 27
developed tumours. The diet containing 0-25 per cent copper was given to 20
rats and only 12 of these developed tumours. The first tumours in both these
groups were found during the third month. The diet containing 0 5 per cent
copper proved toxic and only 5 animals survived 3 months' treatment, but the
liver of all these proved normal on macroscopic and microscopic examination.
Why this level of copper proved toxic is not clear, except that the carcinogen
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used is more powerful than DMAB and the basal diet was even less nutritionally
adequate than maize. They make no mention of a toxic effect due to this level
of copper in control animals given a similar diet without the carcinogen.
Clayton, King and Spain (1953) used copper-free diets and diets containing
either 3-94 or 300 mg./kg. of copper sulphate. Both DMAB and 3'-methyl-
4-dimethylaminoazobenzene were used and with both there was definite protection
against tumour development when the higher concentration of copper was given.
The incidence and severity of cirrhosis was also less in the copper-treated animals.
Actual numbers of animals and times of tumour development are not given
in this short paper.
In a recent paper King, Spain and Clayton (1957), whilst observing the
inhibitory effect of copper acetate on tumour development due to 3'-methyl-
4-dimethylaminoazobenzene, also noted that the addition of copper sulphate
to the synthetic diet they used caused rapid destruction of the carcinogen. They
also observed that their diet, which contained 79 per cent glucose and a con-
siderable quantity of fat, frequently became rancid when copper sulphate was
mixed with it. They concluded that much of the inhibitory effect of the copper
salt on tumour development was due to destruction of the carcinogen. Never-
theless, they were still able to obtain inhibition of tumours when the diet was
freshly prepared every day. Rancidity was never observed in any of the diets
used in the present experiments. Because the diets were freshly prepared at
approximately 10 day intervals and since no evidence of destruction of dye in
the diets has been found over periods of 6 weeks, it is considered that destruction
of the dye can be excluded as a factor in the retardation of tumour development
in the present experiments.
The mechanism whereby copper exerts its protective effect must at present
be a matter for conjecture. There are a number of possibilities. Groups 8, 9,
10 and 11 of Experiment B were designed to reduce the likelihood of a chemical
alteration of the carcinogen under the influence of copper acetate in the gastro-
intestinal tract. The results obtained from these groups are inconclusive since
the tumour incidence and induction times were very different from those in the
control group receiving DMAB every day. Analysis of the histological material
from Groups 4 and 6 receiving copper and DMAB continuously show that the
changes in the liver were similar to those which follow DMAB alone, but less
severe. These observations suggest that DMAB in an active form was reaching
the liver and that any chemical alteration or interference with absorption in the
gut was incomplete.
Kensler, Sugiura and Rhoads (1940) showed that DMAB treatment causes
reduction in the riboflavin content of the liver; Griffin and Baumann (1946)
showed that the reduction of riboflavin in the liver was directly related to the
carcinogenicity of the compound tested. Later Griffin and Baumann (1948)
were able to show that hydrogenated coconut oil, a protective agent, maintained
the riboflavin content of the liver when DMAB was included in the diet. Clayton,
King and Spain (1953) reported that copper feeding, regardless of the simultane-
ous administration of the carcinogen, actually increased the riboflavin content
of the liver. King, Spain and Clayton (1957) using diets containing 3'-methyl-
4-dimethylaminoazobenzene and copper sulphate freshly prepared each day have
reported that the riboflavin content of the liver did not fall so much as when the
diet contained no copper. These observations suggest that the mechanism of
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protection is similar to that of high protein diets and hydrogenated coconut oil,
and is mediated through maintenance ofthe riboflavin content ofthe liver.
The importance of binding of the active carcinogenic derivative of DMAB
to liver proteins has been stressed by Miller and Miller (1955). The major portion
of the bound dye, which is found only in the liver, is associated with some of
the soluble proteins. Copper has the ability to complex very readily with a wide
variety of proteins, and copper salts have been described as being " protein-
avid ". King et al. (1957) estimated the total and bound dye in the liver of their
copper-carcinogen treated animals and found that they did not increase as
rapidly as in those animals not receiving copper. It is not inconceivable that the
metal competes with the active portion of DMAB for binding to protein in the
liver, and so prevents or delays the changes in the protein content of the hepatic
cells which Miller and Miller (1955) envisaged as leading to tumour formation.
Finally there are certain physiological properties of copper through which
the protective effect might be mediated. Copper is concerned with glucose meta-
bolism (Keil and Nelson, 1934). It forms an essential part ofbutyryl-coenzyme A
(Gubler, 1956) which catalyses the first step in the oxidation of short-chain
fatty acids with 3-8 carbon atoms. Copper is aiso concerned in purine meta-
bolism by the copper-containing enzyme, uricase. There is evidence that copper
is required for the activation of the cytochrome reactions and energy transfer
of cells. Copper is also moderately bactericidal and it is possible that ingestion
of high concentrations produces an alteration in the bacterial flora of the bowel,
so that vitamin synthesis in the bowel is altered and the balance upset. Vitamins
of the B group are known to be of importance in hepatic tumour development,
some accelerating tumour development, others retarding it.
Thus it can be seen that copper could alter azo-dye carcinogenesis by a variety
of means, and since it is an essential part of many enzyme and bio-synthetic
reactions it is conceivable that enzymes and reactions which involve copper
may be altered during carcinogenesis and that a high copper diet modifies this.
Alternatively a high copper diet and the consequent tissue storage may itself
inactivate some enzyme system or systems which are involved in the metabolism
of the dye and so prevent tumour development.
SUMIMARY
Experiments are described which show that copper acetate has a powerful
retarding effect on hepatic tumour development in rats treated with DMAB.
Thus, of 16 rats which survived treatment with copper acetate and DMAB for
longer than 6 months, only one animal developed a tumour which was found
after 18 months' treatment. This can be contrasted with a control group
receiving DMAB alone, in which 8 rats all developed tumours in an average time
of 8 5 months.
An assessment of liver damage based on the development of cirrhosis and
regenerative hyperplasia is described. From the analysis of liver tissue obtained
by biopsy during the experiment, and from animals dying without tumours, it
has been found that liver damage and cirrhosis is always much less in copper
acetate-DMAB treated rats than in rats receiving DMAB alone. The spleen
of the copper-treated rats also shows less damage and does not enlarge so much
as in the group treated with DMAB alone.
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Possible mechanisms through which the protective effect might be mediated
are briefly discussed. It has been established that there is no alteration or
destruction of the carcinogen when mixed and stored with copper acetate.
I am indebted to Professor J. W. Orr and Dr. D. L. Woodhouse for valuable
help and advice throughout this investigation. I am also indebted to the
Birmingham Branch of the British Empire Cancer Campaign and to the Medical
Research Fund of the United Birmingham Hospitals for support of this work.
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EXPLANATION OF PLATES
FIG. 1 -Intralobular disorganisation causing compression and distortion of adjacent
sinusoids. H. and V.G. x 125.
FIG. 2.-Nodular hyperplasia and advanced cirrhosis. H. and V.G. x 135.
FIG. 3.-Chronic inflammatory cells and macrophages within a portal tract. Degenerative
changes in periportal liver cells. H. and E. x 250.
FIG. 4.-Inereased numbers of reticulin fibres radiating from portal tracts. Reticulin.
x 140.
FIG. 5.-Fusiform cells extending from portal tract into adjacent parenchyma. H. and E.
x 400.
FIG. 6.-Fusiform cells adjacent to a portal tract arranged in double rows. H. and E.
x 460.
FIG. 7.-Periportal fibrosis (incipient cirrhosis). Delicate strands of fibrous tissue extending
slightly into parenchyma. H. and V.G. x 250.
FIG. 8.-Early cirrhosis. Strands offibrous tissue extending from portal tracts towards other
portal tracts. H. and V.G. x 125.
FIG. 9.-Spleen. Increased prominence of fibrous trabeculae with marked congestion of the
pulp. H. and V.G. x 125.
FIG. 10.-Spleen. Fibrosis of Malpighian body. H. and V.G. x 150.
FIG. 11.-Spleen. Fibrosis ofpiulp. H. and V.G. x 300.BRITSH JOURNAL OF CANCER.
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